24X7 News Guru

The Real Time News

Glenmark Pharma’s API arm files papers with Sebi to unlock value via IPO

Two years ago, Glenmark Pharmaceuticals had attempted to sell a minority stake in its API business to private equity funds but those plans did not fructify. Post the Q3FY21 results, the management indicated that API growth outlook remained strong for the next two-three years owing to a favourable demand-supply scenario. ...

Glenmark Pharma’s API arm files papers with Sebi to unlock value via IPO Two years ago, Glenmark Pharmaceuticals had attempted to sell a minority stake in its API business to private equity funds but those plans did not fructify. Post the Q3FY21 results, the management indicated that API growth outlook remained strong for the next two-three years owing to a favourable demand-supply scenario.

%d bloggers like this: